Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Fate Therapeutics, Inc.
FATE
$2.35
Name : Fate Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $281,578,176.00
EPSttm : -1.05
finviz dynamic chart for FATE
Fate Therapeutics, Inc.
$2.35
0.86%
$0.02
FATE — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

8.22

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.02

EPS Last/This Y

0.13

EPS This/Next Y

0.05

Price

2.35

Target Price

6.19

Analyst Recom

1.91

Performance Q

11.9

Upside

-680.9%

Beta

2.53

Ticker: FATE



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-08-28FATE2.410.220.035323
2026-08-31FATE2.390.2211.005332
2026-09-02FATE2.450.220.045339
2026-09-03FATE2.410.22999.995356
2026-09-04FATE2.470.22999.995356
2026-09-08FATE2.490.220.015357
2026-09-09FATE2.440.210.005538
2026-09-10FATE2.320.210.095565
2026-09-11FATE2.320.210.255562
2026-09-14FATE2.340.210.005561
2026-09-15FATE2.360.210.005570
2026-09-16FATE2.430.212.005575
2026-09-17FATE2.540.200.005559
2026-09-18FATE2.530.200.005565
2026-09-21FATE2.540.200.005195
2026-09-22FATE2.580.200.035217
2026-09-23FATE2.430.190.005379
2026-09-24FATE2.340.190.075537
2026-09-25FATE2.360.190.025742
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-08-28FATE2.415.6- -1.02
2026-08-31FATE2.405.6- -1.02
2026-09-01FATE2.445.6- -1.02
2026-09-02FATE2.455.6- -1.02
2026-09-03FATE2.445.6- -1.02
2026-09-04FATE2.475.6- -1.02
2026-09-08FATE2.495.6- -1.02
2026-09-09FATE2.435.6- -1.02
2026-09-10FATE2.325.6- -1.02
2026-09-11FATE2.325.6- -1.02
2026-09-14FATE2.335.6- -1.02
2026-09-15FATE2.365.6- -1.02
2026-09-16FATE2.365.6- -1.02
2026-09-17FATE2.535.6- -1.02
2026-09-18FATE2.535.6- -1.02
2026-09-21FATE2.545.6- -1.02
2026-09-22FATE2.595.6- -1.02
2026-09-23FATE2.435.6- -1.02
2026-09-24FATE2.345.6- -1.02
2026-09-25FATE2.355.6- -1.02
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-08-28FATE-2.33-1.897.46
2026-08-31FATE-2.33-1.907.46
2026-09-01FATE-2.33-1.907.46
2026-09-02FATE-2.33-1.907.46
2026-09-03FATE-2.33-1.907.46
2026-09-04FATE-2.33-1.907.46
2026-09-08FATE-2.33-1.897.46
2026-09-09FATE-2.33-1.897.46
2026-09-10FATE-2.33-1.897.46
2026-09-11FATE-2.39-1.897.98
2026-09-14FATE-2.39-1.897.98
2026-09-15FATE-2.39-1.897.98
2026-09-16FATE-2.39-1.897.98
2026-09-17FATE-2.39-1.897.98
2026-09-18FATE-2.39-1.897.98
2026-09-21FATE-2.39-1.897.98
2026-09-23FATE-2.39-1.897.98
2026-09-24FATE-2.39-1.897.98
2026-09-25FATE-2.39-1.898.22
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-0.25

Avg. EPS Est. Current Quarter

-0.26

Avg. EPS Est. Next Quarter

-0.27

Insider Transactions

-2.39

Institutional Transactions

-1.89

Beta

2.53

Average Sales Estimate Current Quarter

1

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

12

Growth Score

24

Sentiment Score

59

Actual DrawDown %

96.5

Max Drawdown 5-Year %

-99

Target Price

6.19

P/E

Forward P/E

PEG

P/S

43.39

P/B

1.79

P/Free Cash Flow

EPS

-1.05

Average EPS Est. Cur. Y​

-1.02

EPS Next Y. (Est.)

-0.97

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1941.09

Relative Volume

1.35

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-88.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

◆ FATE Healthcare
$2.35
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
14/20
Pullback
21/25
Volume
3/15
Valuation
10/20
TP/AR
3/10
Options
8/10
RSI
43.3
Range 1M
21.7%
Sup Dist
3.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
36 /100
WEAK
Momentum
7/25
Growth
14/30
Estimates
2/20
Inst/Vol
5/15
Options
8/10
EPS Yr
7.1%
EPS NY
1.6%
52W%
61.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +163.4% upside
Quality
2/30
Valuation
16/30
Growth
8/25
Stability
5/10
LT Trend
1/5
Upside
+163.4%
Quality
12
Click a card to see score breakdown Full Analysis →
FATE — P/E HistoricalBiotechnology
Fate Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 161
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.
FATE

Latest News

—
Caricamento notizie per FATE…
stock quote shares FATE – Fate Therapeutics, Inc. Stock Price stock today
news today FATE – Fate Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FATE – Fate Therapeutics, Inc. yahoo finance google finance
stock history FATE – Fate Therapeutics, Inc. invest stock market
stock prices FATE premarket after hours
ticker FATE fair value insiders trading